Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 healthcare AI stocks to buy according to hedge funds. On June 30, 2025, ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the 10 Stocks Crash Hard on a Roaring Monday. Tempus AI dropped for a second day on ...

Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s ...

Tempus AI, Inc. ("Tempus") (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...

Tempus AI, Inc. ("Tempus") (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...

The lawsuit stems from last month's report that claimed Tempus overstates its AI capabilities and engages in "aggressive ...

Tempus AI (NasdaqGS:TEM) recently saw its market presence elevated as it was added to multiple Russell indices, showcasing an enhanced visibility. The company also bolstered its strategic partnerships ...

Tempus AI's innovation in genomics, data, and applications makes the company well positioned to become a contender in the AI ...

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market opportunities. See why TEM stock is a Buy.

Tempus AI delivered adjusted EBITDA of -$21.8 million in the third quarter, which was a $14.4 million year-over-year improvement and also a significant improvement quarter over quarter.

Tempus AI, a precision medicine company that, as its name implies, uses artificial intelligence to process medical data, popped in its stock market debut Friday, with shares jumping 15%.